Divi's Laboratories revenue and financials

DIVISLAB · NSE · INR

₹9,550.00+3.85%+₹354.00

Close · October 6, 2026

In the fiscal year ended March 2026, Divi's Laboratories reported revenue of ₹104.76B (+12.34% year over year). Net income was ₹25.68B, a net margin of 24.5%.

Annual revenue · 2026: ₹104.76B
  1. ₹76.65B2023
  2. ₹77.96B2024
  3. ₹93.25B2025
  4. ₹104.76B2026

Fiscal year ending in March. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+12.34%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
+17.21%
FY to Mar 2026 vs FY to Mar 2025
Net margin
24.5%
FY to Mar 2025: 23.5%

Financial data

Amounts in millions of INR; per-share values in INR; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q2 2025Q1 2025
Total revenue30,80028,31026,04024,10025,850
Cost of revenue9,86011,1909,4509,5609,810
Gross profit20,94017,12016,59014,54016,040
Operating income11,2208,1407,7206,1707,790
EBIT11,8609,6907,8607,3608,650
EBITDA13,19010,8909,0408,4809,720
Interest expense60.060.060.030.010.0
Pre-tax income11,8009,6307,8007,3308,640
Income tax2,7802,1201,9701,8802,020
Net income9,0207,5105,8305,4506,620
Net income to common shareholders9,0207,5105,8305,4506,620
Basic EPS33.9528.3121.9820.4924.93
Diluted EPS33.9528.3121.9820.4924.93
Average shares (basic)266265265266266
Average shares (diluted)266265265266266